Introduction: The natural history, the progression of a disease process in an individual over time, has not yet been fully elucidated in hidradenitis suppurativa (HS). In this large multicenter study, we aimed to investigate the natural history of HS and its gender differences. Methods: This cross-sectional study included 827 patients. The chronological order of the clinical manifestations for each patient was recorded retrospectively. Sociodemographic characteristics, triggering factors, clinical, treatment, and prognostic features were also evaluated. Results: The mean age of disease onset was significantly younger in women than in men (22.42 ± 9.28 vs. 27.06 ± 20.56, p < 0.001) and those with a family history (p < 0.0001). The mean disease duration was 91.17 ± 83.64 months. The most common symptom was purulent discharge (81%). The mean duration of abscess was shorter in women than in men (3.11 ± 2.65 vs. 3.75 ± 3.75, p = 0.01). The axilla was the most common onset area followed by the inguinal and gluteal regions. The disease ran a more severe course in men. Abscess/inflammatory nodule was defined in the last 6 months in 88.6% of the patients; however, the first 5 years of the disease were the most active disease period in 67.5% of the patients. Multivariate analysis revealed being male, older age, family history, involvement of the axillary, inguinal, and perianal regions independently associated with HS severity. While antibiotic use was the most important factor in improving the disease symptoms, stress was the most common aggravating factor. Biological therapy in men, laser epilation and pregnancy in women were significant alleviating factors, whereas weight gain was a more common aggravating factor for women. Conclusion: HS shows a relentlessly progressive course with inflammatory attacks, but the first years of the disease are the most active period. This study confirms that environmental and hormonal factors may play an important role in the disease course, probably with other endogenous or exogenous factors.

Background

The natural history, the progression of a disease process in an individual over time, has not yet been fully elucidated in hidradenitis suppurativa (HS). In this large multicenter study, we aimed to investigate the natural history of HS and its gender differences.

Summary

This cross-sectional study included 827 patients. The axilla was the most common onset area followed by the inguinal and gluteal regions. The disease ran a more severe course in men. Multivariate analysis revealed being male, older age, family history, involvement of the axillary, inguinal, and perianal regions independently associated with HS severity. While antibiotic use was the most important factor in improving the disease symptoms, stress was the most common aggravating factor. Biological therapy in men, laser epilation and pregnancy in women were significant alleviating factors, whereas weight gain was a more common aggravating factor for women. HS shows a relentlessly progressive course with inflammatory attacks, but the first years of the disease are the most active period.

1.
Zouboulis
CC
,
Desai
N
,
Emtetam
L
,
Hunger
RE
,
Ioannides
D
,
Juhász
I
, et al
.
European S1 guideline for the treatment of hidradenitis suppuratia/acne inversa
.
J Eur Acad Dermatol Venereol
.
2015
;
29
(
4
):
619
44
.
2.
von der Werth
JM
,
Williams
HC
.
The natural history of hidradenitis suppurativa
.
J Eur Acad Dermatol Venereol
.
2000
;
14
(
5
):
389
92
.
3.
Özkur
E
,
Karadağ
AS
,
Üstüner
P
,
Aksoy
B
,
Eşme
P
,
Çalışkan
E
, et al
.
Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity
.
Clin Exp Dermatol
.
2021
;
46
(
3
):
532
40
.
4.
Martorell
A
,
Jfri
A
,
Koster
SBL
,
Gomez-Palencia
P
,
Solera
M
,
Alfaro-Rubio
A
, et al
.
Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study
.
J Eur Acad Dermatol Venereol
.
2020
;
34
(
6
):
1309
18
.
5.
Schrader
AMR
,
Deckers
IE
,
Van Der Zee
HH
,
Boer
J
,
Prens
EP
.
Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity
.
J Am Acad Dermatol
.
2014
;
71
(
3
):
460
7
.
6.
Vasanth
V
,
Chandrashekar
BS
.
Follicular occlusion tetrad
.
Indian Dermatol Online J
.
2014
;
5
(
4
):
491
3
.
7.
Goldburg
SR
,
Strober
BE
,
Payette
MJ
.
Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis
.
J Am Acad Dermatol
.
2020
;
82
(
5
):
1045
58
.
8.
Revuz
J
,
Canoui-Poitrine
F
,
Wolkenstein
P
,
Viallette
C
,
Gabison
G
,
Pouget
F
, et al
.
Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies
.
J Am Acad Dermatol
.
2008
;
59
(
4
):
596
601
.
9.
Yang
JH
,
Moon
J
,
Kye
YC
,
Kim
KJ
,
Kim
MN
,
Ro
YS
, et al
.
Demographic and clinical features of hidradenitis suppurativa in Korea
.
J Dermatol
.
2018
;
45
(
12
):
1389
95
.
10.
Von Der Werth
JM
,
Williams
HC
,
Raeburn
JA
.
The clinical genetics of hidradenitis suppurativa revisited
.
Br J Dermatol
.
2000
;
142
(
5
):
947
53
.
11.
Kurokawa
I
,
Hayashi
N
;
Japan Acne Research Society
.
Questionnaire surveillance of hidradenitis suppurativa in Japan
.
J Dermatol
.
2015
;
42
(
7
):
747
9
.
12.
Yüksel
M
,
Basım
P
.
Demographic and clinical features of hidradenitis suppurativa in Turkey
.
J Cutan Med Surg
.
2020
;
24
(
1
):
55
9
.
13.
Mammadli
K
,
Bilgic
A
,
Alpsoy
E
.
Sociodemographic, clinical, treatment characteristics and natural course of hidradenitis suppurativa: a single centre case series of 100 patients
.
Exp Dermatol
.
2021
;
31
:
77
8
.
14.
Bilgic
A
,
Fettahlıoglu Karaman
B
,
Demirseren
DD
,
Cınar
L
,
Kacar
N
,
Türel Ermertcan
A
, et al
.
Internalized stigma in Hidradenitis Suppurativa; A multicenter cross-sectional study
.
Dermatology
.
2023
;
239
(
3
):
445
53
.
15.
Omine
T
,
Miyagi
T
,
Hayashi
K
,
Yamaguchi
S
,
Takahashi
K
.
Clinical characteristics of hidradenitis suppurativa patients in Okinawa, Japan: differences between East Asia and Western countries
.
J Dermatol
.
2020
;
47
(
8
):
855
62
.
16.
Vossen
AR
,
van Straalen
KR
,
Prens
EP
,
van der Zee
HH
.
Menses and pregnancy affect symptoms in hidradenitis suppurativa: a cross-sectional study
.
J Am Acad Dermatol
.
2017
;
76
(
1
):
155
6
.
17.
Barth
JH
,
Layton
AM
,
Cunliffe
WJ
.
Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa
.
Br J Dermatol
.
1996
;
134
(
6
):
1057
9
.
18.
Macklis
PC
,
Tyler
K
,
Kaffenberger
J
,
Kwatra
S
,
Kaffenberger
BH
.
Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients
.
Arch Dermatol Res
.
2022
;
314
(
3
):
293
300
.
19.
Molinelli
E
,
Sapigni
C
,
Simonetti
O
,
Brisigotti
V
,
Giuliodori
K
,
Offidani
A
.
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: a controlled prospective clinical study
.
J Am Acad Dermatol
.
2022
;
87
(
3
):
674
5
.
20.
Seivright
JR
,
Villa
NM
,
Grogan
T
,
Parvataneni
RK
,
Thompson
AM
,
Shi
VY
, et al
.
Impact of pregnancy on hidradenitis suppurativa disease course: a systematic review and meta-analysis
.
Dermatology
.
2022
;
238
(
2
):
260
6
.
21.
Perng
P
,
Zampella
JG
,
Okoye
GA
.
Considering the impact of pregnancy on the natural history of hidradenitis suppurativa
.
Br J Dermatol
.
2018
;
178
(
1
):
13
4
.
22.
Kromann
CB
,
Deckers
IE
,
Esmann
S
,
Boer
J
,
Prens
EP
,
Jemec
GB
.
Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study
.
Br J Dermatol
.
2014
;
171
(
4
):
819
24
.
23.
Barth
JH
,
Layton
AM
,
Cunliffe
WJ
.
Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa
.
Br J Dermatol
.
1996
;
134
(
6
):
1057
9
.
You do not currently have access to this content.